Your browser doesn't support javascript.
loading
Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools.
Giovannetti, E; Zucali, P A; Assaraf, Y G; Funel, N; Gemelli, M; Stark, M; Thunnissen, E; Hou, Z; Muller, I B; Struys, E A; Perrino, M; Jansen, G; Matherly, L H; Peters, G J.
Afiliación
  • Giovannetti E; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, Department of Translational Research and The New Technologies in Medicine and Surgery, University of Pisa, Pisa.
  • Zucali PA; Department of Oncology, University of Milan, Humanitas Clinical and Research Hospital, Rozzano (Milan), Italy.
  • Assaraf YG; Department of Biology, Fred Wyszkowski Cancer Research Laboratory, Technion-Institute of Technology, Haifa, Israel.
  • Funel N; Cancer Pharmacology Lab, AIRC Start-Up Unit, Department of Translational Research and The New Technologies in Medicine and Surgery, University of Pisa, Pisa.
  • Gemelli M; Department of Oncology, University of Milan, Humanitas Clinical and Research Hospital, Rozzano (Milan), Italy.
  • Stark M; Department of Biology, Fred Wyszkowski Cancer Research Laboratory, Technion-Institute of Technology, Haifa, Israel.
  • Thunnissen E; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Hou Z; Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA.
  • Muller IB; Department of Clinical Chemistry, VU University Medical Center, Amsterdam.
  • Struys EA; Department of Clinical Chemistry, VU University Medical Center, Amsterdam.
  • Perrino M; Department of Oncology, University of Milan, Humanitas Clinical and Research Hospital, Rozzano (Milan), Italy.
  • Jansen G; Amsterdam Rheumatology and Immunology Center - Location VUmc, Amsterdam, The Netherlands.
  • Matherly LH; Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA.
  • Peters GJ; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands. Electronic address: gj.peters@vumc.nl.
Ann Oncol ; 28(11): 2725-2732, 2017 Nov 01.
Article en En | MEDLINE | ID: mdl-28945836
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Transportador de Folato Acoplado a Protón / Proteína Portadora de Folato Reducido / Pemetrexed / Mesotelioma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Transportador de Folato Acoplado a Protón / Proteína Portadora de Folato Reducido / Pemetrexed / Mesotelioma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido